Iris Valdés

1.1k total citations
49 papers, 884 citations indexed

About

Iris Valdés is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Iris Valdés has authored 49 papers receiving a total of 884 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Public Health, Environmental and Occupational Health, 35 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Iris Valdés's work include Mosquito-borne diseases and control (43 papers), Viral Infections and Vectors (27 papers) and Viral Infections and Outbreaks Research (22 papers). Iris Valdés is often cited by papers focused on Mosquito-borne diseases and control (43 papers), Viral Infections and Vectors (27 papers) and Viral Infections and Outbreaks Research (22 papers). Iris Valdés collaborates with scholars based in Cuba, Thailand and Kenya. Iris Valdés's co-authors include Gerardo Guillén, Lisset Hermida, Laura Lazo, Lázaro Gil, María G. Guzmán, Ernesto Marcos, Yaremis Romero, Jorge Martı́n, Javier Menéndez and Alienys Izquierdo and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Virology.

In The Last Decade

Iris Valdés

48 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iris Valdés Cuba	20	702	645	136	121	102	49	884
Lisset Hermida Cuba	22	1.0k 1.5×	930 1.4×	184 1.4×	163 1.3×	89 0.9×	64	1.2k
Laura Lazo Cuba	21	749 1.1×	682 1.1×	139 1.0×	127 1.0×	53 0.5×	46	848
Lázaro Gil Cuba	18	531 0.8×	484 0.8×	101 0.7×	98 0.8×	44 0.4×	43	649
Tomohiro Ishikawa Japan	15	477 0.7×	416 0.6×	116 0.9×	61 0.5×	90 0.9×	35	688
Nicholas P. Olivarez United States	6	550 0.8×	527 0.8×	77 0.6×	44 0.4×	103 1.0×	6	720
Ana P. Goncalvez United States	12	814 1.2×	699 1.1×	112 0.8×	65 0.5×	57 0.6×	14	930
Wen-Yang Tsai United States	14	651 0.9×	586 0.9×	136 1.0×	93 0.8×	97 1.0×	24	860
Caren Chancey United States	11	543 0.8×	534 0.8×	77 0.6×	42 0.3×	47 0.5×	22	754
John Catalan United States	13	863 1.2×	810 1.3×	181 1.3×	71 0.6×	38 0.4×	18	1.0k
Ravithat Putvatana United States	10	1.1k 1.6×	989 1.5×	105 0.8×	119 1.0×	92 0.9×	11	1.3k

Countries citing papers authored by Iris Valdés

Since Specialization

Citations

This map shows the geographic impact of Iris Valdés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Valdés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Valdés more than expected).

Fields of papers citing papers by Iris Valdés

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Valdés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Valdés. The network helps show where Iris Valdés may publish in the future.

Co-authorship network of co-authors of Iris Valdés

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Valdés. A scholar is included among the top collaborators of Iris Valdés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Valdés. Iris Valdés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Valdés, Iris, Edith Suzarte Portal, Laura Lazo, et al.. (2024). Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice. Vaccine. 42(25). 126213–126213. 2 indexed citations

Mendoza‐Marí, Yssel, et al.. (2023). Preparing for the Next Pandemic: Increased Expression of Interferon-Stimulated Genes After Local Administration of Nasalferon or HeberNasvac. DNA and Cell Biology. 43(2). 95–102. 3 indexed citations

Valdés, Iris, Lázaro Gil, Laura Lazo, et al.. (2023). Recombinant protein based on domain III and capsid regions of zika virus induces humoral and cellular immune response in immunocompetent BALB/c mice. Vaccine. 41(40). 5892–5900. 2 indexed citations

Valdés, Iris, et al.. (2017). Evaluation in Mice of the Immunogenicity of a Tetravalent Subunit Vaccine Candidate Against Dengue Virus Using Mucosal and Parenteral Immunization Routes. Viral Immunology. 30(5). 350–358. 5 indexed citations

Valdés, Iris, Ernesto Marcos, Edith Suzarte Portal, et al.. (2017). A dose-response study in mice of a tetravalent vaccine candidate composed of domain III-capsid proteins from dengue viruses. Archives of Virology. 162(8). 2247–2256. 11 indexed citations

Delgado-Martínez, Rafael, Alexander Hernández, Yanelys Morera Díaz, et al.. (2017). Vaccine CIGB 247 is potentially safe for use as a novel therapeutic vaccine against cancer in Chlorocebus aethiops monkeys. International Immunopharmacology. 48. 55–60. 1 indexed citations

Marcos, Ernesto, Lázaro Gil, Alienys Izquierdo, et al.. (2016). A dose-response study in mice of the vaccine preparation containing the diiic-2 protein aggregated with the oligodeoxinucleotide 39m. Bionatura. 1(1). 6–12. 5 indexed citations

Marcos, Ernesto, Laura Lazo, Lázaro Gil, et al.. (2016). Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response. Immunology Letters. 176. 51–56.

Valdés, Iris, David Skibinski, Ying Xiu Toh, et al.. (2015). Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice. Vaccine. 33(12). 1474–1482. 16 indexed citations

10.

Valdés, Iris, Lázaro Gil, Laura Lazo, et al.. (2015). Could an experimental dengue virus infection fail to induce solid immunity against homologous viral challenge in non-human primates?. Archives of Virology. 161(2). 465–470. 5 indexed citations

11.

Portal, Edith Suzarte, Ernesto Marcos, Lázaro Gil, et al.. (2014). Generation and characterization of potential dengue vaccine candidates based on domain III of the envelope protein and the capsid protein of the four serotypes of dengue virus. Archives of Virology. 159(7). 1629–1640. 31 indexed citations

12.

Gil, Lázaro, Alienys Izquierdo, Laura Lazo, et al.. (2014). Capsid protein: Evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys. Virology. 456-457. 70–76. 21 indexed citations

13.

Izquierdo, Alienys, Laura Lazo, Lázaro Gil, et al.. (2014). A tetravalent dengue vaccine containing a mix of domain III-P64k and domain III-capsid proteins induces a protective response in mice. Archives of Virology. 159(10). 2597–2604. 14 indexed citations

14.

Valdés, Iris, Lázaro Gil, Yaremis Romero, et al.. (2013). Olive baboons: a non-human primate model for testing dengue virus type 2 replication. International Journal of Infectious Diseases. 17(12). e1176–e1181. 7 indexed citations

15.

Marcos, Ernesto, Lázaro Gil, Laura Lazo, et al.. (2012). Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus. Archives of Virology. 158(1). 225–230. 17 indexed citations

16.

Gil, Lázaro, Carlos López, Laura Lazo, et al.. (2009). The Cellular Immune Response Plays an Important Role in Protecting Against Dengue Virus in the Mouse Encephalitis Model. Viral Immunology. 22(1). 23–30. 37 indexed citations

17.

Valdés, Iris, Lisset Hermida, Lázaro Gil, et al.. (2009). Heterologous prime-boost strategy in non-human primates combining the infective dengue virus and a recombinant protein in a formulation suitable for human use. International Journal of Infectious Diseases. 14(5). e377–e383. 20 indexed citations

18.

Gil, Luiz Fernando, Carolina B. López, Laura Lazo, et al.. (2009). Recombinant nucleocapsid-like particles from dengue-2 virus induce protective CD4+ and CD8+ cells against viral encephalitis in mice. International Immunology. 21(10). 1175–1183. 27 indexed citations

19.

López, Carlos, Lázaro Gil, Laura Lazo, et al.. (2009). In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus. Archives of Virology. 154(4). 695–698. 38 indexed citations

20.

Zulueta, Aı́da, Lisset Hermida, Laura Lazo, et al.. (2003). The fusion site of envelope fragments from each serotype of Dengue virus in the P64k protein, influence some parameters of the resulting chimeric constructs. Biochemical and Biophysical Research Communications. 308(3). 619–626. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact